Published in Am J Pharm Educ on May 10, 2011
A depression training session with consumer educators to reduce stigmatizing views and improve pharmacists' depression care attitudes and practices. Am J Pharm Educ (2013) 0.78
Impact of a Mental Illness Stigma Awareness Intervention on Pharmacy Student Attitudes and Knowledge. Am J Pharm Educ (2016) 0.77
Mental health curricula at schools of pharmacy in the United Kingdom and recent graduates' readiness to practice. Am J Pharm Educ (2013) 0.75
Emphasizing Bloom's Affective Domain to Reduce Pharmacy Students' Stigmatizing Attitudes. Am J Pharm Educ (2017) 0.75
Global pattern of experienced and anticipated discrimination against people with schizophrenia: a cross-sectional survey. Lancet (2009) 7.32
Lessons from social psychology on discrediting psychiatric stigma. Am Psychol (1999) 3.63
Dispelling the stigma of schizophrenia: what sort of information is best? Schizophr Bull (1994) 2.53
Familiarity with and social distance from people who have serious mental illness. Psychiatr Serv (2001) 2.47
Prejudice, social distance, and familiarity with mental illness. Schizophr Bull (2001) 1.95
Stigma and mental health professionals: a review of the evidence on an intricate relationship. Int Rev Psychiatry (2007) 1.94
Factors influencing social distance toward people with mental illness. Community Ment Health J (2004) 1.64
Attitudes of pharmacy students toward mental illness. Am J Hosp Pharm (1990) 1.60
Attitudes toward mental illness in medical students: does personal and professional experience with mental illness make a difference? Med Educ (2000) 1.59
Familiarity with mental illness and social distance from people with schizophrenia and major depression: testing a model using data from a representative population survey. Schizophr Res (2004) 1.48
Peer-level patient presenters decrease pharmacy students' social distance from patients with schizophrenia and clinical depression. Am J Pharm Educ (2008) 1.45
Pharmacy students' and graduates' attitudes towards people with schizophrenia and severe depression. Am J Pharm Educ (2006) 1.30
A study of stigmatized attitudes towards people with mental health problems among health professionals. J Psychiatr Ment Health Nurs (2009) 1.25
Public attitudes towards people with mental illness in six German cities: results of a public survey under special consideration of schizophrenia. Eur Arch Psychiatry Clin Neurosci (2002) 1.24
Desire for social distance from people with mental disorders. Aust N Z J Psychiatry (2009) 1.23
Changing the attitudes of 'tomorrow's doctors' towards mental illness and psychiatry: a comparison of two teaching methods. Med Educ (1998) 1.16
A comparative study of consumer participation in mental health pharmacy education. Ann Pharmacother (2006) 1.09
Determinants of mental health stigma among pharmacy students in Australia, Belgium, Estonia, Finland, India and Latvia. Int J Soc Psychiatry (2009) 1.07
Perceived stigma among individuals with common mental disorders. J Affect Disord (2009) 1.07
Pharmacy students' attitudes toward and professional interactions with people with mental disorders. Int J Soc Psychiatry (2008) 1.01
The relationship between mental health literacy, personal contacts and personal stigma against depression. J Affect Disord (2008) 0.98
Putting the person back into psychopathology: an intervention to reduce mental illness stigma in the classroom. Soc Psychiatry Psychiatr Epidemiol (2008) 0.96
Undergraduate nursing students' attitudes towards mental health nursing: determining the influencing factors. Contemp Nurse (2007) 0.83
Effect of psychiatric labels on attitudes toward mental illness in a Turkish sample. Int J Soc Psychiatry (1994) 0.82
Social distance in response to psychiatric labels. Int J Rehabil Res (2002) 0.78
The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med (2005) 2.34
Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. Med Care (2006) 2.28
Effect of exposure to evidence-based pharmacotherapy on outcomes after acute myocardial infarction in older adults. J Am Geriatr Soc (2012) 1.58
Coverage and use of prescription drugs in nursing homes: implications for the medicare modernization act. Med Care (2006) 1.46
Age and sex trends in long-term opioid use in two large American health systems between 2000 and 2005. Pain Med (2009) 1.38
Treatment of dementia in community-dwelling and institutionalized medicare beneficiaries. J Am Geriatr Soc (2007) 1.32
Assessing the impact of coverage gaps in the Medicare Part D drug benefit. Health Aff (Millwood) (2006) 1.32
A controlled study of the effects of state surveillance on indicators of problematic and non-problematic benzodiazepine use in a Medicaid population. Int J Psychiatry Med (2004) 1.24
Quality of psychopharmacological medication prescribing and mortality in Medicare beneficiaries in nursing homes. J Am Geriatr Soc (2014) 1.22
Association of antipsychotic use with hospital events and mortality among medicare beneficiaries residing in long-term care facilities. Am J Geriatr Psychiatry (2009) 1.17
Increased persistency in medication use by U.S. Medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings. Diabetes Care (2009) 1.07
Effects of state surveillance on new post-hospitalization benzodiazepine use. Int J Qual Health Care (2003) 1.01
Evaluation of nationally mandated drug use reviews to improve patient safety in nursing homes: a natural experiment. J Am Geriatr Soc (2005) 1.01
Inappropriate drug use and risk of transition to nursing homes among community-dwelling older adults. Med Care (2006) 1.00
Racial and ethnic disparities in the treatment of dementia among Medicare beneficiaries. J Gerontol B Psychol Sci Soc Sci (2008) 0.96
Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population. Am J Geriatr Pharmacother (2012) 0.96
A secondary analysis of a duration response association between selective serotonin reuptake inhibitor use and the risk of acute myocardial infarction in the aging population. Ann Epidemiol (2008) 0.94
How Medicare Part D benefit phases affect adherence with evidence-based medications following acute myocardial infarction. Health Serv Res (2013) 0.93
Lack of relationship between long-term use of benzodiazepines and escalation to high dosages. Psychiatr Serv (2003) 0.93
Impact of maintenance therapy on hospitalization and expenditures for Medicare beneficiaries with chronic obstructive pulmonary disease. Am J Geriatr Pharmacother (2010) 0.92
Pharmacotherapeutic management of dementia across settings of care. J Am Geriatr Soc (2013) 0.92
Racial disparities in access after regulatory surveillance of benzodiazepines. Arch Intern Med (2006) 0.90
Benzodiazepine use and expenditures for Medicare beneficiaries and the implications of Medicare Part D exclusions. Psychiatr Serv (2008) 0.89
Changing patterns in medication use with increasing probability of death for older Medicare beneficiaries. J Am Geriatr Soc (2010) 0.88
Effects of depression diagnosis and antidepressant treatment on mortality in Medicare beneficiaries with chronic obstructive pulmonary disease. J Am Geriatr Soc (2013) 0.87
Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry (2013) 0.87
The effect of a three-tier formulary on antidepressant utilization and expenditures. J Ment Health Policy Econ (2008) 0.85
Stability of transgenes in long-term micropropagation of plants of transgenic birch (Betula platyphylla). Biotechnol Lett (2010) 0.84
Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults. Am J Geriatr Pharmacother (2008) 0.84
US trends in glycemic control, treatment, and comorbidity burden in patients with diabetes. J Clin Hypertens (Greenwich) (2010) 0.83
Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities. Am J Geriatr Pharmacother (2009) 0.82
Medication use and adherence among elderly Medicare beneficiaries with diabetes enrolled in Part D and retiree health plans. Med Care (2011) 0.82
Effects of pill burden on discontinuation of the initial HAART regimen in minority female patients prescribed 1 pill/day versus any other pill burden. AIDS Care (2013) 0.82
Impact of Part D low-income subsidies on medication patterns for Medicare beneficiaries with diabetes. Med Care (2012) 0.82
Increases in opioid medication use: balancing the good with the bad. Pain (2008) 0.82
Health care use in depressed, elderly, cardiac patients and the effect of antidepressant use. Am J Health Syst Pharm (2009) 0.81
Increased Rates of Mild Traumatic Brain Injury Among Older Adults in US Emergency Departments, 2009-2010. J Head Trauma Rehabil (2016) 0.81
Antiparkinson drug use and adherence in medicare part D beneficiaries with Parkinson's disease. Clin Ther (2013) 0.79
Effect of medications on physical function and cognition in nursing home residents with dementia. J Am Geriatr Soc (2014) 0.79
Influence of prescription monitoring programs on analgesic utilization by an insured retiree population. Pharmacoepidemiol Drug Saf (2012) 0.79
Use of drugs with anticholinergic properties among nursing home residents with dementia: a national analysis of Medicare beneficiaries from 2007 to 2008. Drugs Aging (2015) 0.78
Obesity status and colorectal cancer screening in the United States. J Obes (2013) 0.78
Algorithm for Identifying Nursing Home Days Using Medicare Claims and Minimum Data Set Assessment Data. Med Care (2016) 0.78
Associations of depression diagnosis and antidepressant treatment with mortality among young and disabled Medicare beneficiaries with COPD. Gen Hosp Psychiatry (2013) 0.77
[Effects of the body fat mass and blood sugar and plasma resistin to slim exercise prescription for overweight and obesity students]. Wei Sheng Yan Jiu (2013) 0.76
The effect of dementia on medication use and adherence among Medicare beneficiaries with chronic heart failure. Am J Geriatr Pharmacother (2012) 0.76
Medication patterns for Medicare beneficiaries with SNF/LTC facility stays. Health Care Financ Rev (2008) 0.75
Sex differences in mortality following isolated traumatic brain injury among older adults. J Trauma Acute Care Surg (2016) 0.75
Response to Lapane and colleagues. J Am Geriatr Soc (2015) 0.75
Risk of Stroke Among Older Medicare Antidepressant Users With Traumatic Brain Injury. J Head Trauma Rehabil (2016) 0.75
Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortality. Cardiol Res Pract (2009) 0.75
Perceptions of benzodiazepine dependence among women age 65 and older. J Gerontol Soc Work (2014) 0.75
Prevention of Trastuzumab and Anthracycline-induced Cardiotoxicity Using Angiotensin-converting Enzyme Inhibitors or β-blockers in Older Adults With Breast Cancer. Am J Clin Oncol (2017) 0.75
Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population. Curr Med Res Opin (2009) 0.75
Dimethyl sulfoxide participant iron-mediated cascade oxidation/α-formylation reaction of substituted 2,3-dihydropyrroles under air and protonic acid free condition. J Org Chem (2014) 0.75
Prescribing trends and drug budget impact of the ARBs in the UK. Value Health (2008) 0.75
Patterns of treatment modifications among newly treated hypertensive patients: does choice of modification strategy affect likelihood of treatment discontinuation? J Hypertens (2016) 0.75
Association of authorized generic marketing with prescription drug spending on antidepressants from 2000 to 2011. J Am Pharm Assoc (2003) (2017) 0.75